Catalyst Wire Dossier Catalyst Wire Dossier

S(+)-Ibuprofen

S-ibuprofen (S(+)-enantiomer) · Gebro Pharma GmbH
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for S(+)-Ibuprofen, covering 2012-03-13 to 2023-07-17. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain [Phase 2]

See pricing